BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11230883)

  • 1. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders.
    Weinmann M; Becker G; Einsele H; Bamberg M
    Radiother Oncol; 2001 Mar; 58(3):235-46. PubMed ID: 11230883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders.
    Paulino AC; Reddy SP
    Am J Hosp Palliat Care; 1996; 13(6):32-5. PubMed ID: 8945101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of low-dose splenic irradiation for the treatment of chronic lymphocytic and prolymphocytic leukaemias.
    Singh AK; Bates T; Wetherley-Mein G
    Scand J Haematol; 1986 Jul; 37(1):50-8. PubMed ID: 3489979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic irradiation in chronic lymphocytic leukemia.
    Chisesi T; Capnist G; Dal Fior S
    Eur J Haematol; 1991 Apr; 46(4):202-4. PubMed ID: 2015875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Splenic irradiation: apropos of 8 cases. Clinical indications and literature review].
    Ibáñez Villoslada C; González San Segundo C; de Torres Olombrada MV; García García R; Santos Miranda JA
    An Med Interna; 2007 May; 24(5):231-4. PubMed ID: 17907888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic irradiation for prolymphocytic leukemia: is it preferable as an initial treatment or not?
    Yamamoto K; Hamaguchi H; Nagata K; Shibuya H; Takeuchi H
    Jpn J Clin Oncol; 1998 Apr; 28(4):267-9. PubMed ID: 9657013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic irradiation as primary therapy for prolymphocytic leukemia.
    Kiss A; Haubenstock A; Bognar H; Scheiderbauer R; al-Mobarak M; Base W
    Am J Hematol; 1989 Mar; 30(3):188-9. PubMed ID: 2916562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of chronic haematological malignancies.
    Ho AD
    Baillieres Clin Haematol; 1991 Jan; 4(1):197-221. PubMed ID: 2039859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic irradiation for splenomegaly: A systematic review.
    Zaorsky NG; Williams GR; Barta SK; Esnaola NF; Kropf PL; Hayes SB; Meyer JE
    Cancer Treat Rev; 2017 Feb; 53():47-52. PubMed ID: 28063304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose palliative radiotherapy for splenomegaly in hematologic disorders.
    Lavrenkov K; Krepel-Volsky S; Levi I; Ariad S
    Leuk Lymphoma; 2012 Mar; 53(3):430-4. PubMed ID: 21848363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
    Moccia F; Casti P; Morra L
    Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic irradiation for hairy cell leukaemia.
    al-Moundhri M; Graham PH
    Australas Radiol; 1997 Nov; 41(4):361-2. PubMed ID: 9409029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity.
    Zhang B; Lewis SM
    Eur J Haematol; 1989 Jul; 43(1):63-6. PubMed ID: 2767243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
    Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
    J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of splenic irradiation in chronic lymphocytic leukemia.
    Guiney MJ; Liew KH; Quong GG; Cooper IA
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):225-9. PubMed ID: 2912945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
    Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
    Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
    Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
    Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment.
    Troussard X; Maitre E
    J Cell Mol Med; 2024 Feb; 28(3):e18060. PubMed ID: 38095234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of low-malignancy lymphomas by spleen irradiation].
    Słomkowski M; Jeleniewska A; Apel D; Sablińska K; Maj S
    Acta Haematol Pol; 1990; 21(1):85-91. PubMed ID: 2260412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.